SCM
RMD icon

Sterling Capital Management’s ResMed RMD Stock Holding History

Sterling Capital Management’s Portfolio RMD Stock Details RMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$902K Sell
4,016
-2,855
-42% -$711K 0.02% 539
2025
Q4 		$1.66M Sell
6,871
-89
-1% -$22.8K 0.03% 461
2025
Q3 		$1.91M Sell
6,960
-664
-9% -$181K 0.03% 411
2025
Q2 		$1.97M Buy
7,624
+1,597
+26% +$381K 0.03% 399
2025
Q1 		$1.35M Sell
6,027
-896
-13% -$209K 0.02% 499
2024
Q4 		$1.58M Buy
6,923
+2,150
+45% +$518K 0.02% 492
2024
Q3 		$1.17M Buy
+4,773
New +$1.07M 0.02% 541

Other funds holding RMD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
DAM
Diamant Asset Management Ridgefield, Connecticut $137B AUM 18.02% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Sterling Capital Management's RMD Position: Q1 2026 in Review

Sterling Capital Management reduced its ResMed (RMD) stake by 42% in Q1 2026, selling an estimated $711K and leaving 4,016 shares worth $902K. The position accounts for 0.02% of the portfolio, ranked #539.

Sterling Capital Management first reported a position in RMD in Q3 2024 and has held it in 7 quarters since. The position peaked at $1.97M in Q2 2025. 938 funds tracked by Wall St. Rank hold RMD as of Q1 2026.

  • Sterling Capital Management held 4,016 shares of ResMed worth $902K as of Q1 2026.
  • Sterling Capital Management sold 2,855 ResMed shares in Q1 2026, an estimated $711K.
  • ResMed made up 0.02% of Sterling Capital Management's portfolio in Q1 2026, its #539 holding.
  • Sterling Capital Management first reported a position in ResMed in Q3 2024 and has held it in 7 quarters since.
  • Sterling Capital Management's ResMed position peaked at $1.97M in Q2 2025.
  • 938 funds tracked by Wall St. Rank held ResMed as of Q1 2026.

Based on Sterling Capital Management's 13F filing for Q1 2026, filed 22 Apr 2026.